 |
| FILE PHOTO: The Pfizer logo is pictured on their headquarters building - Jonathan Stempel |
Published: November 24, 2021
By: Jonathan Stempel
(Reuters) - Pfizer Inc has sued a longtime employee for allegedly stealing "scores" of confidential documents, including some related to its COVID-19 vaccine, as she prepared to jump to a competitor.
In a complaint filed on Tuesday in San Diego federal court, Pfizer said Chun Xiao Li breached her confidentiality agreement by uploading more than 12,000 files without permission to her personal accounts and devices from her company-issued laptop.
The alleged materials include a Sept. 24 "playbook" containing internal assessments and recommendations about the Pfizer/BioNTech COVID-19 vaccine, Pfizer's relationship with its German vaccine partner, and presentations related to cancer antibodies.
Pfizer said Li, an associate director of statistics, tried repeatedly to cover her tracks, even providing a "decoy" laptop to fool it into thinking what she did with the files.
Li "has misled Pfizer about what she took, how she took it, when and why she did it, and where those files (and possibly others) can be found," the New York-based drugmaker said.
Pfizer said Li is resigning after 15 years at the company, and appears to have an offer to join Xencor Inc, a California clinical-stage company focusing on treatments for cancer and autoimmune diseases, on Nov. 29.
Li could not immediately be reached for comment through her LinkedIn account. Xencor is not a defendant in the lawsuit, and declined to comment.
Pfizer said competitors have been trying to recruit its employees "relentlessly, especially during 2021."
Discerning the Mystery is a website dedicated to awakening and educating the people to their true potential of mental, spiritual, emotional, and physical growth. It can be difficult work, but if just one person benefits from these efforts, it is entirely worth it.
If you enjoy what you read here, please give the post a like and share on social media. Also, if you enjoyed this article, please consider leaving a donation.
If you enjoy what you read here, please give the post a like and share on social media. Also, if you enjoyed this article, please consider leaving a donation.
Feel free to send us an email and tell us what you think. If you have any suggestions or subjects you would like to see discussed, please let us know.
Thank you for your support.
No comments:
Post a Comment